Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1699-3055
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer ; day:31 ; month:8 ; year:2019 ; pages:1-8
Clinical and translational oncology ; (31.8.2019), 1-8
- Creator
-
Kirwan, C. C.
Descamps, T.
Castle, J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-019-02197-6
- URN
-
urn:nbn:de:101:1-2020011318472278181781
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
11.12.2125, 10:48 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kirwan, C. C.
- Descamps, T.
- Castle, J.
- SpringerLink (Online service)
Other Objects (12)
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
Biomarkers in cancer/Circulating tumour markers
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
Circulating Tumour DNA in Melanoma—Clinic Ready?
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
Biomarkers in cancer/Circulating tumour markers
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
Circulating Tumour DNA in Melanoma—Clinic Ready?
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
Biomarkers in cancer/Circulating tumour markers
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
Circulating Tumour DNA in Melanoma—Clinic Ready?
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA